SCHEMBL175552

SCHEMBL175552

C=CCc1cccc(O)c1Oc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.46
GABRB2 P47870 2/20 0.46
AKR1B1 P15121 1/20 0.40
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CASP1 P29466 1/20 0.37
HSD17B10 Q99714 1/20 0.37
LTA4H P09960 2/20 0.36
NR1H2 P55055 1/20 0.36
BAX Q07812 1/20 0.36
XDH P47989 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
GLA P06280 1/20 0.35
HTT P42858 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylether SCHEMBL27761425 0.85 GABRA1 (0.46) GABRA1GABRB2AKR1B1GAALTA4H
SCHEMBL27618720 0.81 GABRA1 (0.39) GABRA1GABRB2MEN1KMT2AGAA
SCHEMBL10525766 0.81 GABRA1 (0.39) GABRA1GABRB2MEN1KMT2AGAA
SCHEMBL3264284 0.80 FOLH1 (0.41) GABRA1GABRB2MEN1KMT2AGAA
SCHEMBL7656115 0.80 GABRA1 (0.40) GABRA1GABRB2AKR1B1MEN1KMT2A
SCHEMBL3739900 0.78 GABRA1 (0.50) GABRA1GABRB2AKR1B1MEN1KMT2A
SCHEMBL981489 0.78 KDM4E (0.47) GABRA1GABRB2AKR1B1GAAKDM4E
SCHEMBL28577075 0.78 HTT (0.37) GABRA1GABRB2MEN1KMT2AGAA
SCHEMBL6546165 0.78 PTK2B (0.38) GABRA1GABRB2MEN1KMT2AGAA
SCHEMBL774629 0.77 HRH1 (0.44) KDM4EALDH1A1ADRA2AADRA2BADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006071674-A2 ORAL CARE COMPOSITIONS CONTAINING A EUCALYPTUS EXTRACT COLGATE-PALMOLIVE COMPANY (US) 2006-07-06 WO claimed
US-20060140883-A1 Oral care compositions containing a eucalyptus extract COLGATE-PALMOLIVE COMPANY 2006-06-29 US claimed
EP-2424488-B1 MICROENCAPSULATED COMPOSITIONS AND METHODS FOR TISSUE MINERALIZATION PREMIER DENTAL PRODUCTS CO (US) 2023-06-07 EP disclosed
EP-3237069-A1 ORAL CARE COMPOSITIONS Kiromic, LLC (US) 2017-11-01 EP disclosed
CN-107260575-A High water content oral cavity composition comprising microcrystalline cellulose and carboxymethyl cellulose 高露洁-棕榄公司 2017-10-20 CN disclosed
EP-2866774-B1 HIGH WATER CONTENT ORAL COMPOSITIONS COMPRISING MICROCRYSTALLINE CELLULOSE AND CARBOXYMETHYLCELLULOSE COLGATE PALMOLIVE CO (US) 2017-08-09 EP disclosed
US-9724541-B2 Dental cleaning and polishing composition comprising diamond particles Kao, Lisa Marie (US) 2017-08-08 US disclosed
WO-2016106313-A1 ORAL CARE COMPOSITIONS KIROMIC, LLC (US) 2016-06-30 WO disclosed
CN-103118651-B For microencapsulation compositions and the method for tissue mineralization PREMIER DENTAL PRODUCTS COMPNAY (US) 2016-01-06 CN disclosed
US-20150164769-A1 High Water Content Oral Compositions Comprising Microcrystalline Cellulose and Carboxymethylcellulose COLGATE-PALMOLIVE COMPANY (US) 2015-06-18 US disclosed
EP-2866774-A1 HIGH WATER CONTENT ORAL COMPOSITIONS COMPRISING MICROCRYSTALLINE CELLULOSE AND CARBOXYMETHYLCELLULOSE Colgate-Palmolive Company (US) 2015-05-06 EP disclosed
WO-2006071755-A1 OREGANO ORAL CARE COMPOSITIONS AND METHODS OF USE THEREOF COLGATE-PALMOLIVE COMPANY (US) 2006-07-06 WO disclosed
WO-2006071677-A2 INSTANT TOOTH WHITENING WITH SILICONE RESIN AND SILICONE ADHESIVE COLGATE-PALMOLIVE COMPANY (US) 2006-07-06 WO disclosed
WO-2006068750-A1 ANTI-CARIES ORAL CARE COMPOSITION WITH XYLITOL COLGATE-PALMOLIVE COMPANY (US) 2006-06-29 WO disclosed
US-20060140884-A1 Oregano oral care compositions and methods of use thereof COLGATE-PALMOLIVE COMPANY 2006-06-29 US disclosed
US-20060140883-A1 Oral care compositions containing a eucalyptus extract COLGATE-PALMOLIVE COMPANY 2006-06-29 US disclosed
WO-2006068753-A1 ANTI-CARIES ORAL CARE COMPOSITION WITH A CHELATING AGENT COLGATE-PALMOLIVE COMPANY (US) 2006-06-29 WO disclosed
US-20060142411-A1 Instant tooth whitening with silicone resin and silicone adhesive COLGATE-PALMOLIVE COMPANY 2006-06-29 US disclosed
US-20060134020-A1 Anti-caries oral care composition with a chelating agent COLGATE-PALMOLIVE COMPANY 2006-06-22 US disclosed
WO-2005077326-A1 TOOTH COATING COMPOSITIONS AND METHODS COLGATE-PALMOLIVE COMPANY (US) 2005-08-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060140883-A1 Oral care compositions containing a eucalyptus extract ELANE, MLEC, TAS2R40 GABRA1 4471/4885GABRB2 4813/4885AKR1B1 4830/4885
US-20150164769-A1 High Water Content Oral Compositions Comprising Microcrystalline Cellulose and Carboxymethylcellulose SI, COL14A1, COL2A1 GABRA1 4854/4885GABRB2 4879/4885AKR1B1 3627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.